nonquinonole agents was used. The antibiotics used were amikacin, apramycin, gentamicin, kanamycin, spectinomycin (SPT), STR, CHL, SXT, ampicillin, cefotaxime, and ceftriaxone. Quinolone susceptibility was determined by using the microdilution method according to NCCLS guidelines (14) .
All Y. enterocolitica strains studied showed susceptibility to apramycin, gentamicin, kanamycin, cefotaxime, and ceftriaxone; all were resistant to ampicillin. We only found differences in resistance to STR, SPT, CHL, and SXT. With one exception, all isolates were resistant to STR. Resistance to CHL and SXT was widespread (46 and 42 resistant strains, respectively).
The MICs of nalidixic acid were 2,048 g/ml for 24 (52%) strains, 1,024 g/ml for 6 (13%) strains, 512 g/ml for 3 (6.5%) strains, 256 g/ml for 7 (15.2%) strains, and 128 g/ml for 6 (13%) strains. The MICs of drugs tested against the susceptible strains ranged from 4 to 8 g/ml (Table 1 ). All the studied isolates were susceptible to the tested fluoroquinolones, which had MICs ranging from 0.03 to 2 g/ml. All quinolones showed similar intrinsic activity. The MIC at which 90% of strains were killed for ciprofloxacin, levofloxacin, and trovafloxacin was 1 g/ml, and that for moxifloxacin and ofloxacin was 2 g/ml.
Plasmid DNA was obtained by the procedure of alkaline lysis (9, 12) . Plasmid profile analysis was carried out for all strains, and five plasmid profiles could be identified. Four were as follows: A, those strains that only harbored one plasmid of 44 kb (34 strains); B, those with a plasmid of 57 kb (three strains); C, three strains, each one with two plasmids of 44 and 37 kb; and D, only one strain with two plasmids of 44 and 8 kb. The last profile, E, included a strain that carried a 37-kb plasmid.
Amplification by PCR was used to detect aadA and aphE, the genes that encoded the ANT(3Љ) (9) and APH(3Љ) aminoglycoside-modifying enzymes (AGMEs).
Two oligonucleotide primers, 5Ј-TGATTTGCTGGTTACG GTGAC-3Ј and 5Ј-CGCTATGTTCTCTTGCTTTTG-3Ј, were used to amplify a 284-bp fragment of the aadA gene, a procedure we performed by following the methods described previously by Clark et al. (6) .
Oligonucleotides 5Ј-CAGGAGGAACAGGAGGGTG-3Ј and 5Ј-GGTAAGAAGTCGGGATTGA-3Ј were used to amplify a 230-bp fragment of the aphE gene. Half a colony was resuspended in 25 l of sterile distilled water and boiled for 10 min. Twenty-five microliters of a reaction mixture containing 20 mM Tris-HCl (pH 8.8), 100 mM potassium chloride, 30 mM magnesium chloride, gelatin (0.1%, wt/vol), 400 M deoxynucleoside triphosphates, and a 1 M concentration of each primer was added together with 2.5 U of Taq polymerase (Promega, Madison, Wis.). The reaction was amplified at the following temperature profiles: 30 cycles of 30 s at 94°C, 30 s at 55°C, and 30 s at 72°C, with a final extension at 72°C for 10 min. The AGME study was also carried out for all strains. The aadA gene was found in 48 strains. Among the other three, which did not carry the aadA gene, two were resistant to STR and SPT, and the last one was susceptible to STR but was resistant to SPT. We did not find any strain carrying the aphE gene.
We observed an increase of nalidixic acid resistance in Y. enterocolitica, although the new quinolones are still highly active in vitro. These results agree with those described by Sánchez-Céspedes et al. (21) . These authors showed the clonal spread of one strain that became resistant to nalidixic acid by acquiring mutations in the gyrA gene. Future studies of the mutations which are present in the region that determines the resistance to quinolones will allow us to relate the acquired nalidixic acid resistance levels to the presence of mutations. Plasmids of around 40 to 50 kb could be associated with virulence plasmids. It may be possible that in strains without plasmids, the virulence plasmid has been lost by storage. On the other hand, the low variability of the plasmid and AGME profile supports the possible clonal dissemination of one strain.
Our results suggest the clonal dissemination of a nalidixic acid-susceptible Y. enterocolitica strain that developed resistance to nalidixic acid, probably as a result of selective pressure exerted by the use of fluoroquinolones in humans and especially in animal hosts (7, 20, 25) . Further experiments with additional, more discriminatory markers are in progress to confirm our results. We thank R. Lozano Mantecón for reviewing the manuscript.
